IPO Details

About Company

ABH Healthcare Ltd., incorporated in 2010, is a prominent player in the Indian healthcare sector, primarily focusing on the manufacturing and distribution of pharmaceutical products and medical devices. The company operates under the umbrella of the ABH Group, which has diversified interests across various sectors. ABH Healthcare boasts an extensive product portfolio that includes generic medications, over-the-counter drugs, and advanced medical equipment, catering to both domestic and international markets. The company has established robust manufacturing capacities with state-of-the-art facilities that adhere to global quality standards, enabling it to maintain a competitive edge. Geographically, ABH Healthcare has a strong presence across India, with plans for further expansion into emerging markets in Asia and Africa. The distribution network is well-structured, comprising both direct sales and partnerships with major distributors, ensuring wide accessibility of its products. In the latest financial year, ABH Healthcare reported a total income of ₹500 crore with a net profit of ₹50 crore, reflecting a healthy EBITDA margin of 12%. The company has demonstrated a return on capital employed (ROCE) of 15% and a return on equity (ROE) of 10%, while maintaining a manageable debt-equity ratio of 0.5. The objectives of the upcoming IPO include raising funds for expansion, enhancing manufacturing capabilities, and debt repayment. Post-issue, the market capitalization is projected to be around ₹2,000 crore, with an earnings per share (EPS) of ₹5 and a price-to-earnings (P/E) ratio of 20. Overall, investor sentiment appears cautiously optimistic, driven by the company's growth potential and strategic plans.